Evidence map›Paper›PMID 22981700›Full record

ReviewBlood cells, molecules & diseases2013

Transfusion immunomodulation--the case for leukoreduced and (perhaps) washed transfusions.

Katie L Lannan, Julie Sahler, Sherry L Spinelli, Richard P Phipps, Neil Blumberg

Open access · greenAbstract readReview
In one paragraph

Review in Blood cells, molecules & diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 4 pooled it
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 4 syntheses or guidelines pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Longer RBC storage duration is associated with increased postoperative infections in pediatric cardiac surgery.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2015
    Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Effect of washing units of canine red blood cells on storage lesions.Journal of veterinary internal medicine · 2022
    Article
  16. Review
  17. Review
  18. Red blood cell storage lesion: causes and potential clinical consequences.Blood transfusion = Trasfusione del sangue · 2019
    Review
  19. Article
  20. Characteristics of Extracellular Vesicles in Red Blood Concentrates Change with Storage Time and Blood Manufacturing Method.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Katie L LannanDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Julie Sahler
Sherry L Spinelli
Richard P Phipps
Neil Blumberg
University of Rochester · US

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Martha Susiarjo · 1985 to 2026
$42.8M
Training Program in Oral ScienceT90DE021985 · NIDCR · UNIVERSITY OF ROCHESTER · PI OVITT, CATHERINE, YULE, DAVID I · 2011 to 2021
$5.6M
Identification and Significance of Biologic Mediators in Red Cell ConcentratesR01HL095467 · NHLBI · UNIVERSITY OF ROCHESTER · PI BLUMBERG, NEIL, PHIPPS, RICHARD P. · 2009 to 2012
$1.5M
Platelet Activation and Inflammatory MediatorsR01HL078603 · NHLBI · UNIVERSITY OF ROCHESTER · PI PHIPPS, RICHARD P. · 2004 to 2007
$1.2M
Microparticles as Messengers of Communication Between Blood and Vascular CellsRC1HL100051 · NHLBI · UNIVERSITY OF ROCHESTER · PI PHIPPS, RICHARD P. · 2009 to 2010
$1.0M
NHLBI NIH HHS HL00051NHLBI NIH HHS HL078603NHLBI NIH HHS HL095467NHLBI NIH HHS R01 HL078603NHLBI NIH HHS R01 HL095467NHLBI NIH HHS RC1 HL100051NIDCR NIH HHS T90 DE021985NIEHS NIH HHS ES01247NIEHS NIH HHS P30 ES001247
6 · The paper itself

Abstract

During the last three decades, a growing body of clinical, basic science and animal model data has demonstrated that blood transfusions have important effects on the immune system. These effects include: dysregulation of inflammation and innate immunity leading to susceptibility to microbial infection, down-regulation of cellular (T and NK cell) host defenses against tumors, and enhanced B cell function that leads to alloimmunization to blood group, histocompatibility and other transfused antigens. Furthermore, transfusions alter the balance between hemostasis and thrombosis through inflammation, nitric oxide scavenging, altered rheologic properties of the blood, immune complex formation and, no doubt, several mechanisms not yet elucidated. The net effects are rarely beneficial to patients, unless they are in imminent danger of death due to exsanguination or life threatening anemia. These findings have led to appeals for more conservative transfusion practice, buttressed by randomized trials showing that patients do not benefit from aggressive transfusion practices. At the risk of hyperbole, one might suggest that if the 18th and 19th centuries were characterized by physicians unwittingly harming patients through venesection and bleeding, the 20th century was characterized by physicians unwittingly harming patients through current transfusion practices. In addition to the movement to more parsimonious use of blood transfusions, an effort has been made to reduce the toxic effects of blood transfusions through modifications such as leukoreduction and saline washing. More recently, there is early evidence that reducing the storage period of red cells transfused might be a strategy for minimizing adverse outcomes such as infection, thrombosis, organ failure and mortality in critically ill patients particularly at risk for these hypothesized effects. The present review will focus on two approaches, leukoreduction and saline washing, as means to reduce adverse transfusion outcomes.

Indexed as

Immune SystemTransfusion ReactionBlood BanksCritical IllnessCryopreservationCytapheresisHumansImmunomodulationLeukocyte Reduction ProceduresRandomized Controlled Trials as TopicRetrospective StudiesRisk Factors

Identifiers

PMID22981700
PMCPMC3508165
OpenAlexW2051590794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.